Literature DB >> 33584971

Breast Cancer Health Disparities in Hispanics/Latinas.

Silvia J Serrano-Gomez1, Maria Carolina Sanabria-Salas2, Laura Fejerman3.   

Abstract

PURPOSE OF THE REVIEW: Breast cancer incidence and mortality rates are lower in some Hispanic/Latino subpopulations compared to Non-Hispanic White women. However, studies suggest that the risk of breast cancer-specific mortality is higher in US Hispanics/Latinas. In this review we summarized current knowledge on factors associated with breast cancer incidence and risk of mortality in women of Hispanic/Latino origin. RECENT
FINDINGS: Associative studies have proposed a multiplicity of factors likely contributing to differences in breast cancer incidence and survival between population groups, including socioeconomic/sociodemographic factors, lifestyle choices as well as access to and quality of care. Reports of association between global genetic ancestry overall as well as subtype-specific breast cancer risk among Hispanic/Latinas suggest that incidence and subtype distribution could result from differential exposure to environmental and lifestyle related factors correlated with genetic ancestry as well as germline genetic variation.
SUMMARY: Hispanic/Latino in the United States have been largely underrepresented in cancer research. It is important to implement inclusive programs that facilitate the access of this population to health services and that also include education programs for the community on the importance of screening. In addition, it is important to continue promoting the inclusion of Hispanics/Latinos in genomic studies that allow understanding the biological behavior of this disease in the context of all human genetic diversity.

Entities:  

Keywords:  Breast Neoplasms; Hispanic Americans; Risk factors; diagnosis; genetics

Year:  2020        PMID: 33584971      PMCID: PMC7879708          DOI: 10.1007/s12609-020-00370-3

Source DB:  PubMed          Journal:  Curr Breast Cancer Rep        ISSN: 1943-4588


  101 in total

1.  Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.

Authors:  Xiao-Cheng Wu; Mary Jo Lund; Gretchen G Kimmick; Lisa C Richardson; Susan A Sabatino; Vivien W Chen; Steven T Fleming; Cyllene R Morris; Bin Huang; Amy Trentham-Dietz; Joseph Lipscomb
Journal:  J Clin Oncol       Date:  2011-12-05       Impact factor: 44.544

2.  Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.

Authors:  Christopher R Friese; T May Pini; Yun Li; Paul H Abrahamse; John J Graff; Ann S Hamilton; Reshma Jagsi; Nancy K Janz; Sarah T Hawley; Steven J Katz; Jennifer J Griggs
Journal:  Breast Cancer Res Treat       Date:  2013-03-31       Impact factor: 4.872

3.  Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer enrolled in Medicare Part D.

Authors:  Albert J Farias; Xianglin L Du
Journal:  Med Oncol       Date:  2016-01-19       Impact factor: 3.064

4.  Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.

Authors:  Laura Fejerman; Gary K Chen; Celeste Eng; Scott Huntsman; Donglei Hu; Amy Williams; Bogdan Pasaniuc; Esther M John; Marc Via; Christopher Gignoux; Sue Ingles; Kristine R Monroe; Laurence N Kolonel; Gabriela Torres-Mejía; Eliseo J Pérez-Stable; Esteban González Burchard; Brian E Henderson; Christopher A Haiman; Elad Ziv
Journal:  Hum Mol Genet       Date:  2012-01-06       Impact factor: 6.150

5.  Are immigrant enclaves healthy places to live? The Multi-ethnic Study of Atherosclerosis.

Authors:  Theresa L Osypuk; Ana V Diez Roux; Craig Hadley; Namratha R Kandula
Journal:  Soc Sci Med       Date:  2009-05-08       Impact factor: 4.634

6.  Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women.

Authors:  Laura Fejerman; Mariana C Stern; Elad Ziv; Esther M John; Gabriela Torres-Mejia; Lisa M Hines; Roger Wolff; Wei Wang; Kathy B Baumgartner; Anna R Giuliano; Martha L Slattery
Journal:  Carcinogenesis       Date:  2013-04-04       Impact factor: 4.944

7.  Breast Cancer Screening Among Women by Nativity, Birthplace, and Length of Time in the United States.

Authors:  Tainya C Clarke; Meheret Endeshaw; Denise Duran; Mona Saraiya
Journal:  Natl Health Stat Report       Date:  2019-10

8.  Reducing time-to-treatment in underserved Latinas with breast cancer: the Six Cities Study.

Authors:  Amelie Ramirez; Eliseo Perez-Stable; Frank Penedo; Gregory Talavera; J Emilio Carrillo; María Fernández; Alan Holden; Edgar Munoz; Sandra San Miguel; Kipling Gallion
Journal:  Cancer       Date:  2013-11-12       Impact factor: 6.860

9.  Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.

Authors:  Laura Fejerman; Nasim Ahmadiyeh; Donglei Hu; Scott Huntsman; Kenneth B Beckman; Jennifer L Caswell; Karen Tsung; Esther M John; Gabriela Torres-Mejia; Luis Carvajal-Carmona; María Magdalena Echeverry; Anna Marie D Tuazon; Carolina Ramirez; Christopher R Gignoux; Celeste Eng; Esteban Gonzalez-Burchard; Brian Henderson; Loic Le Marchand; Charles Kooperberg; Lifang Hou; Ilir Agalliu; Peter Kraft; Sara Lindström; Eliseo J Perez-Stable; Christopher A Haiman; Elad Ziv
Journal:  Nat Commun       Date:  2014-10-20       Impact factor: 14.919

Review 10.  Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.

Authors:  Marcia Cruz-Correa; Julyann Pérez-Mayoral; Julie Dutil; Miguel Echenique; Rafael Mosquera; Keila Rivera-Román; Sharee Umpierre; Segundo Rodriguez-Quilichini; Maria Gonzalez-Pons; Myrta I Olivera; Sherly Pardo
Journal:  Hered Cancer Clin Pract       Date:  2017-01-21       Impact factor: 2.857

View more
  2 in total

1.  Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivors.

Authors:  Claire C Conley; Jessica N Rivera Rivera; Eida M Castro-Figueroa; Laura Moreno; Julie Dutil; Jennifer D García; Charité Ricker; Gwendolyn P Quinn; Hatem Soliman; Susan T Vadaparampil
Journal:  Transl Behav Med       Date:  2022-10-07       Impact factor: 3.626

2.  Reducing Metabolic Dysregulation in Obese Latina and/or Hispanic Breast Cancer Survivors Using Physical Activity (ROSA) Trial: A Study Protocol.

Authors:  Paola Gonzalo-Encabo; Rebekah L Wilson; Dong-Woo Kang; Mary K Norris; Hajime Uno; Cami N Christopher; Christina Chow; Nathalie Sami; Frank S Fox; Jennifer A Ligibel; Christina M Dieli-Conwright
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.